Home
>
National Drug Code (NDC)
>
Neostigmine Methylsuflate
Neostigmine Methylsuflate - 52584-033-25 - (Neostigmine Methylsuflate)
Drug Information of Neostigmine Methylsuflate
| Product NDC: | 52584-033 |
| Proprietary Name: | Neostigmine Methylsuflate |
| Non Proprietary Name: | Neostigmine Methylsuflate |
| Active Ingredient(s): | 1 mg/mL & nbsp; Neostigmine Methylsuflate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Neostigmine Methylsuflate
| Product NDC: | 52584-033 |
| Labeler Name: | General Injectables & Vaccines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20100801 |
Package Information of Neostigmine Methylsuflate
| Package NDC: | 52584-033-25 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 BAG (52584-033-25) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Neostigmine Methylsuflate
| NDC Code | 52584-033-25 |
| Proprietary Name | Neostigmine Methylsuflate |
| Package Description | 1 VIAL, MULTI-DOSE in 1 BAG (52584-033-25) > 10 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 52584-033 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Neostigmine Methylsuflate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20100801 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | General Injectables & Vaccines, Inc |
| Substance Name | NEOSTIGMINE METHYLSULFATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
